Conserved programmed cell death patterns associate with subtype-specific therapeutic response across multiple cancer types
BACKGROUND: Molecular subtyping may offer a promising path toward a unified framework for precision oncology. We sought to characterize the patterns of programmed cell death (PCD), a pivotal cellular process shaping both intrinsic tumor malignancy and the tumor microenvironment, to better understand tumor heterogeneity. METHODS: We performed integrative multi-cohort transcriptomic analyses encompassing four canonical PCD modes across multiple cancer types. We identified PCD subtypes using nonnegative matrix factorization (NMF), characterized their molecular features and clinical relevance, and developed a streamlined 20-gene classifier to facilitate subtype assignment. RESULTS: We identified five conserved PCD subtypes with distinct genomic alterations, cellular stresses, malignant traits, prognostic outcomes, and immune landscapes. In the immunotherapy setting, PCD subtypes were associated with distinct outcomes across multiple cancer types, with the pyroptosis-dominant (PCD-P) subtype showing the most favorable outcomes. The 20-gene classifier showed good discriminatory performance across independent cohorts. Finally, we proposed candidate subtype-specific therapeutic strategies. CONCLUSION: This study establishes a comprehensive framework for characterizing PCD patterns in cancer, laying the groundwork for biomarker discovery and rational therapeutic design that warrant future evaluation of efficacy and toxicity. FUNDING: National Key R&D Program of China; National Natural Science Foundation of China; Fundamental Research Funds for the Central Universities, Sun Yat-sen University; HE Science Foundation; Young Talents Program of Sun Yat-sen University Cancer Center; Academician Workstation of Jun Ma; Specific Research Fund of the Innovation Platform for Academicians of Hainan Province; Shenzhen Medical Research Fund; Guangdong Basic and Applied Basic Research Foundation.
Authors
- Dong‐Hong Wu (ORCID: https://orcid.org/0000-0001-9795-7172)
- Ziwei Huang (ORCID: https://orcid.org/0000-0001-7517-0395)
- Yan‐Ling Wu (ORCID: https://orcid.org/0000-0003-0332-736X)
- Xiong Zou (ORCID: https://orcid.org/0000-0002-4524-8750)
- Jingjing Zhang (ORCID: https://orcid.org/0000-0002-9155-8979)
- Zihan Wang (ORCID: https://orcid.org/0009-0007-7793-5145)
- Jia‐Wei Lv (ORCID: https://orcid.org/0000-0001-9278-0929)
- Jia-Yi Shen
- Yi-Zhe Cheng
- Zi-An Fang
- Yu-Pei Chen
- Jun Ma
- Shuang Wang
- Yi Liu
Institutions
- Sun Yat-sen University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Sun Yat-sen University Cancer Center (CN)
- Third Affiliated Hospital of Sun Yat-sen University (CN)
- State Key Laboratory of Oncology in South China (CN)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1172/jci203289
- Primary Topic
- Cell death mechanisms and regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province